About Salignostics

The Salignostics team is comprised of experts in the fields of saliva research, tech development, and business development. Our founders have 15 years of experience in the field as innovators and product developers. Our R&D leaders have extensive experience in the market and are key figures in the  diagnostics industry.

Non-invasive, simple and accessible diagnostics is considered a vital goal as it allows for accurate monitoring of health status, disease onset and progression, as well as treatment outcomes. Saliva is the optimal diagnostic body-fluid for non-invasive diagnostic modalities. However, due to technological hurdles, almost no Rapid Diagnostic Testing (RDT) utilizing saliva, are available.


Salignostics Ltd has developed cutting-edge technologies which transform saliva into a reliable body-fluid for lateral flow immunoassays like the hCG Pregnancy Rapid Test and the HRP2 Rapid Test for the detection of Malaria. The ingenuity of these technologies lies in the ability to overcome physiological obstacles found in the chemical, biological and physical features of saliva. Our method provides a revolutionary technological platform for saliva diagnostics.

We believe that utilizing saliva in RDT applications will create the next generation of rapid diagnostics. By significantly lowering costs, increasing accessibility, safety, simplicity and optimizing user-friendliness in a non-invasive and painless test, Salignostics will transform the RDT landscape.

Our Team

  • Aaron Palmon (DMD, PhD) Co-Founder, President
    Aaron Palmon (DMD, PhD)
    • VP R&D of the Hebrew University
    • Former dean of The Hebrew University – Hadassah School of Dental Medicine Founded by the Alpha Omega Fraternity
    • Head and founder of the Hebrew University Teaching and Learning Center
    • 25 years of experience as a Principle Investigator at the Hebrew university
    • Previously, Associate editor at Oral Diseases journal.
    • Author of over 60 peer reviewed scientific articles, 14 competitive grants, patents and winner of 20 international awards in the field of saliva diagnostics and salivary glands regenerative therapy
  • Omer Deutsch (DMD, PhD) Co-Founder, CEO
    Omer Deutsch (DMD, PhD)
    • Extensive 10 years experience in leading variety of biotech research projects in fields such as proteomics , orthodontics, and diagnostics
    • Inventor of 4 patents in the field of salivary diagnostics
    • Fund-raising and investor relations experience
    • Author and contributor of 12 peer reviewed scientific articles in the field of saliva proteomics and diagnostics
  • Guy Krief (PhD) Co-Founder, Deputy CEO and CBDO
    Guy Krief (PhD)
    • Former experience as a business executive of bio-medical start-ups in the field of stem cells therapy for breast cancer
    • Developer of novel technologies in the fields of cancer therapy and bio-markers identification for several applications
    • Inventor of 3 patents in the field of diagnostics and molecular cell biology
    • Author and contributor of 8 peer reviewed scientific articles in the field of saliva proteomics and diagnostics
  • Raluca Cohen (PhD) Co-Founder, CSO
    Raluca Cohen (PhD)
    • Developer and inventor of new saliva based diagnostic approaches
    • Developer of new stem-cell therapy methodologies
    • Broad experience in development of both in-vivo and in vitro models for irradiation diseases
    • Saliva proteomics expert
    • Extensive laboratory experience in the fields of: Microsurgery, cell culture, molecular biology, stem cells isolation and cultivation, tissue engineering and stem sell transplantation therapy
    • Awardee of the Dean’s Award for Excellence 2015
    • Awardee of five international awards for novelty and excellence in salivary research
  • Hagai Dror Chief Strategy & BD
    Hagai Dror
    • Expert in health policy and economics, healthcare strategy development and implementation, and in leading strategic healthcare initiatives.
    • Former head of Healthcare Israel – the international development and collaboration arm of the Israeli Ministry of Health.
    • Former head of Israeli Ministry of Health technology and innovation team in response to COVID-19
    • Former head of Planning and budgeting at the Israeli Ministry of Health.
    • Hagai leads Salignostics’ business development activity and partnerships with multi-national companies, global partners and healthcare organizations.
  • Yoav Neumann (PhD) Co-Founder, CFO
    Yoav Neumann (PhD)
    • Advisor of bio-medical start-ups
    • Former business executive experience in a bio-medical start-up developing stem-cells based therapy for breast cancer
    • Expert in Study Design and Leader of both commercial and scientific oriented projects
    • Developer of several laboratory methods integrating approaches from Multiple scientific disciplines
    • Strategic planning for new products pipeline
    • Winner of 4 international awards for excellent scientific achievements
Aaron Palmon (DMD, PhD)
Aaron Palmon (DMD, PhD)
Co-Founder, President
  • VP R&D of the Hebrew University
  • Former dean of The Hebrew University – Hadassah School of Dental Medicine Founded by the Alpha Omega Fraternity
  • Head and founder of the Hebrew University Teaching and Learning Center
  • 25 years of experience as a Principle Investigator at the Hebrew university
  • Previously, Associate editor at Oral Diseases journal.
  • Author of over 60 peer reviewed scientific articles, 14 competitive grants, patents and winner of 20 international awards in the field of saliva diagnostics and salivary glands regenerative therapy
Omer Deutsch (DMD, PhD)
Omer Deutsch (DMD, PhD)
Co-Founder, CEO
  • Extensive 10 years experience in leading variety of biotech research projects in fields such as proteomics , orthodontics, and diagnostics
  • Inventor of 4 patents in the field of salivary diagnostics
  • Fund-raising and investor relations experience
  • Author and contributor of 12 peer reviewed scientific articles in the field of saliva proteomics and diagnostics
Guy Krief (PhD)
Guy Krief (PhD)
Co-Founder, Deputy CEO and CBDO
  • Former experience as a business executive of bio-medical start-ups in the field of stem cells therapy for breast cancer
  • Developer of novel technologies in the fields of cancer therapy and bio-markers identification for several applications
  • Inventor of 3 patents in the field of diagnostics and molecular cell biology
  • Author and contributor of 8 peer reviewed scientific articles in the field of saliva proteomics and diagnostics
Raluca Cohen (PhD)
Raluca Cohen (PhD)
Co-Founder, CSO
  • Developer and inventor of new saliva based diagnostic approaches
  • Developer of new stem-cell therapy methodologies
  • Broad experience in development of both in-vivo and in vitro models for irradiation diseases
  • Saliva proteomics expert
  • Extensive laboratory experience in the fields of: Microsurgery, cell culture, molecular biology, stem cells isolation and cultivation, tissue engineering and stem sell transplantation therapy
  • Awardee of the Dean’s Award for Excellence 2015
  • Awardee of five international awards for novelty and excellence in salivary research
Hagai Dror
Hagai Dror
Chief Strategy & BD
  • Expert in health policy and economics, healthcare strategy development and implementation, and in leading strategic healthcare initiatives.
  • Former head of Healthcare Israel – the international development and collaboration arm of the Israeli Ministry of Health.
  • Former head of Israeli Ministry of Health technology and innovation team in response to COVID-19
  • Former head of Planning and budgeting at the Israeli Ministry of Health.
  • Hagai leads Salignostics’ business development activity and partnerships with multi-national companies, global partners and healthcare organizations.
Yoav Neumann (PhD)
Yoav Neumann (PhD)
Co-Founder, CFO
  • Advisor of bio-medical start-ups
  • Former business executive experience in a bio-medical start-up developing stem-cells based therapy for breast cancer
  • Expert in Study Design and Leader of both commercial and scientific oriented projects
  • Developer of several laboratory methods integrating approaches from Multiple scientific disciplines
  • Strategic planning for new products pipeline
  • Winner of 4 international awards for excellent scientific achievements

Contact Us

    X